BetterLife Pharma Inc. (CSE:BETR)

Canada flag Canada · Delayed Price · Currency is CAD
0.1000
-0.0050 (-5.56%)
Apr 22, 2025, 2:47 PM EDT
-4.76%
Market Cap 12.57M
Revenue (ttm) n/a
Net Income (ttm) -4.09M
Shares Out n/a
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 226,050
Average Volume 34,298
Open 0.1000
Previous Close 0.1000
Day's Range 0.1000 - 0.1000
52-Week Range 0.0800 - 0.1950
Beta 1.68
RSI 61.39
Earnings Date May 30, 2025

About BetterLife Pharma

BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company’s products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benz... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 7
Stock Exchange Canadian Securities Exchange
Ticker Symbol BETR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.